Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis

BackgroundIncreased PD-1 expression on CD8+ T cells is considered as a hallmark for T-cell exhaustion, and is thought to be related to the prognosis of cancer patients. However, discrepant results have made it difficult to apply PD-1+CD8+T cells and tumor prognosis to clinical practice. Therefore, w...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiyong Wan, Meng Cui, Jia Yang, Dan Liao, Junliang Chen, Fanmin Li, Yin Xiang, Zhiwei Cui, Yang Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1531219/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841540197448155136
author Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang
author_facet Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang
author_sort Zhiyong Wan
collection DOAJ
description BackgroundIncreased PD-1 expression on CD8+ T cells is considered as a hallmark for T-cell exhaustion, and is thought to be related to the prognosis of cancer patients. However, discrepant results have made it difficult to apply PD-1+CD8+T cells and tumor prognosis to clinical practice. Therefore, we conducted a meta-analysis to evaluate its prognostic value in human cancers.MethodsPRISMA reporting guidelines were strictly followed for conducting the current meta-analysis. The PubMed, Web of Science, Embase databases were searched from inception to November 2024. The pooled Hazard Ratio (HR) along with 95% confidence intervals (CIs) of each article were combined for the associations of PD-1+CD8+ T cells with overall survival (OS), progression- free survival (PFS) and disease-free survival(DFS). Subgroup analyses were performed for area, specimen type, cancer type, treatment, detected method and cancer stage.ResultsA total of 20 studies (23 cohorts, 3086 cancer patients) were included in our study. The expression PD-1+CD8+ T cells in cancer patients tended to predict poor overall survival (OS) (HR: 1.379, 95%CI: 1.084-1.753, p= 0.009), and unfavorable disease-free survival(DFS) (HR: 1.468, 95%CI: 0.931-2.316, p=0.099), though it did not reach statistical significance. Begg’s and Egger’s test demonstrated that no obvious publication bias was exist.ConclusionsHigh PD-1 expression on CD8+ T cells is associated with worse survival outcomes, which can be potentially used as a prognostic marker of malignant tumor.
format Article
id doaj-art-52128da3bfe248e9801bfa413ba90eff
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-52128da3bfe248e9801bfa413ba90eff2025-01-14T05:10:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.15312191531219Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysisZhiyong Wan0Meng Cui1Jia Yang2Dan Liao3Junliang Chen4Fanmin Li5Yin Xiang6Zhiwei Cui7Yang Yang8Department of General Practice, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of General Practice, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaDepartment of Medical Laboratory, People’s Hospital of Leshan, Leshan, ChinaBackgroundIncreased PD-1 expression on CD8+ T cells is considered as a hallmark for T-cell exhaustion, and is thought to be related to the prognosis of cancer patients. However, discrepant results have made it difficult to apply PD-1+CD8+T cells and tumor prognosis to clinical practice. Therefore, we conducted a meta-analysis to evaluate its prognostic value in human cancers.MethodsPRISMA reporting guidelines were strictly followed for conducting the current meta-analysis. The PubMed, Web of Science, Embase databases were searched from inception to November 2024. The pooled Hazard Ratio (HR) along with 95% confidence intervals (CIs) of each article were combined for the associations of PD-1+CD8+ T cells with overall survival (OS), progression- free survival (PFS) and disease-free survival(DFS). Subgroup analyses were performed for area, specimen type, cancer type, treatment, detected method and cancer stage.ResultsA total of 20 studies (23 cohorts, 3086 cancer patients) were included in our study. The expression PD-1+CD8+ T cells in cancer patients tended to predict poor overall survival (OS) (HR: 1.379, 95%CI: 1.084-1.753, p= 0.009), and unfavorable disease-free survival(DFS) (HR: 1.468, 95%CI: 0.931-2.316, p=0.099), though it did not reach statistical significance. Begg’s and Egger’s test demonstrated that no obvious publication bias was exist.ConclusionsHigh PD-1 expression on CD8+ T cells is associated with worse survival outcomes, which can be potentially used as a prognostic marker of malignant tumor.https://www.frontiersin.org/articles/10.3389/fonc.2024.1531219/fullPD-1+CD8+ T cellsoverall survivalprogression-free survivaldisease-free survivalcancer
spellingShingle Zhiyong Wan
Meng Cui
Jia Yang
Dan Liao
Junliang Chen
Fanmin Li
Yin Xiang
Zhiwei Cui
Yang Yang
Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
Frontiers in Oncology
PD-1+CD8+ T cells
overall survival
progression-free survival
disease-free survival
cancer
title Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
title_full Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
title_fullStr Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
title_full_unstemmed Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
title_short Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
title_sort prognostic significance of programmed cell death 1 expression on cd8 t cells in various cancers a systematic review and meta analysis
topic PD-1+CD8+ T cells
overall survival
progression-free survival
disease-free survival
cancer
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1531219/full
work_keys_str_mv AT zhiyongwan prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT mengcui prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT jiayang prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT danliao prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT junliangchen prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT fanminli prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT yinxiang prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT zhiweicui prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis
AT yangyang prognosticsignificanceofprogrammedcelldeath1expressiononcd8tcellsinvariouscancersasystematicreviewandmetaanalysis